Cargando…

Trends in Iran Pharmaceutical Market

Detalles Bibliográficos
Autor principal:	Cheraghali, Abdol Majid
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Shaheed Beheshti University of Medical Sciences 2017
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5423229/ https://www.ncbi.nlm.nih.gov/pubmed/28496457

Ejemplares similares

Biosimilars; a unique opportunity for Iran national health sector and national pharmaceutical industry
por: Cheraghali, Abdol Majid
Publicado: (2012)

Impacts of international sanctions on Iranian pharmaceutical market
por: Cheraghali, Abdol Majid
Publicado: (2013)

Policies and measures implemented to reduce the impact of international sanctions on Iran's pharmaceutical sector
por: Emami, Farideh, et al.
Publicado: (2022)

Cost effectiveness of Iran national plasma contract fractionation program
por: Cheraghali, Abdol Majid
Publicado: (2012)

Implications of Confidential Unit Exclusion in Providing Sufficient Safe Blood for the National Health System
por: Cheraghali, Abdol Majid
Publicado: (2011)

Blood safety concerns in the Eastern Mediterranean region
por: Cheraghali, Abdol Majid
Publicado: (2011)

Heavy Metals Contamination of Table Salt Consumed in Iran
por: Cheraghali, Abdol Majid, et al.
Publicado: (2010)

Evaluation of prescriptions of medicines not included in Iran medicine list: A cross-sectional study
por: Zargaran, Marzieh, et al.
Publicado: (2016)

A review of pharmaceutical policies in response to economic crises and sanctions
por: Kheirandish, Mehrnaz, et al.
Publicado: (2015)

Trend analysis of the pharmaceutical market in Iran; 1997–2010; policy implications for developing countries
por: Kebriaeezadeh, Abbas, et al.
Publicado: (2013)

The Structure of the World Pharmaceutical Market: Prioritizing Iran’s Target Export Markets
por: Shabaninejad, Hosein, et al.
Publicado: (2019)

The structure of the pharmaceutical market in Iran using concentration indices
por: Mohseni, Mohammad, et al.
Publicado: (2017)

An Export-Marketing Model for Pharmaceutical Firms (The Case of Iran)
por: Mohammadzadeh, Mehdi, et al.
Publicado: (2013)

The Perspective of Therapeutic Antibody Marketing in Iran: Trend and Estimation by 2025
por: Golpour, Monireh, et al.
Publicado: (2021)

Perspective of pharmaceutical sciences in Iran; Jobs remaining
por: Abdollahi, M.
Publicado: (2011)

Transgenic Animals in Pharmaceutical and Biological Research in Iran
por: Faizi, Mehrdad
Publicado: (2013)

Recent Trends in Pharmaceutical Analytical Chemistry
por: Zacharis, Constantinos K., et al.
Publicado: (2020)

Alignment is the Most Efficient Tool in the Management of the Pharmaceutical Turbulent Market
por: Mohammadzadeh, Mahdi
Publicado: (2014)

Pharmaceuticals Market, Consumption Trends and Disease Incidence Are Not Driving the Pharmaceutical Research on Water and Wastewater
por: González Peña, Omar Israel, et al.
Publicado: (2021)

Translating Nanotechnology from Bench to Pharmaceutical Market: Barriers, Success, and Promises
por: Date, Abhijit A., et al.
Publicado: (2012)

New Trends in Freeze-Drying of Pharmaceutical Products
por: Pisano, Roberto, et al.
Publicado: (2023)

Evaluation of Factors Affecting Prescribing Behaviors, in Iran Pharmaceutical Market by Econometric Methods
por: Tahmasebi, Nima, et al.
Publicado: (2015)

Recent Trends in Pharmaceutical Radiochemistry for Molecular PET Imaging
por: Prante, Olaf, et al.
Publicado: (2014)

Overview of Blood Transfusion System of Iran: 2002–2011
por: Cheraghali, AM
Publicado: (2012)

Does Portuguese pharmaceutical market follow an innovative trend? The INFOMED database analysis
por: Avelar, FG, et al.
Publicado: (2022)

The impact of sanction and healthcare system reform on the healthcare performance and pharmaceutical market in Iran; 2001-2016
por: Zartab, Saman, et al.
Publicado: (2020)

Comparison of Bypassing Agents in Bleeding Reduction in Treatment of Bleeding Episodes in Patients With Haemophilia and Inhibitors
por: Golestani, Mina, et al.
Publicado: (2014)

Health-Related Quality of Life and Health Utility Values in Beta Thalassemia Major Patients Receiving Different Types of Iron Chelators in Iran
por: Seyedifar, Meysam, et al.
Publicado: (2016)

Pharmaceutical market and health system in the Middle Eastern and Central Asian countries: Time for innovations and changes in policies and actions
por: Abdollahias, Akbar, et al.
Publicado: (2011)

Peculiarity of Pharmaceutical Marketing in Serbia
por: Dickov, Veselin
Publicado: (2015)

China's Pharmaceutical Market: Business Environment and Market Dynamics
por: Brueckner, Michael, et al.
Publicado: (2005)

A system dynamics model for national drug policy
por: Abdollahiasl, Akbar, et al.
Publicado: (2014)

Visual Impairment in Kurdistan and Trend of Epidemiologic Eye Studies in Iran
por: Kallestrup, Per
Publicado: (2019)

Pharmaceutical subsidy policy in Iran: a qualitative stakeholder analysis
por: Olyaaeemanesh, Alireza, et al.
Publicado: (2021)

Pharmaceutical market access in emerging markets: concepts, components, and future
por: Kumar, Anuj, et al.
Publicado: (2014)

The Influence of Emerging Markets on the Pharmaceutical Industry
por: Tannoury, Maya, et al.
Publicado: (2017)

Pharmaceutical Marketing and the Invention of the Medical Consumer
por: Applbaum, Kalman
Publicado: (2006)

Pharmaceutical nanotechnology: from the bench to the market
por: Mazayen, Zaed M., et al.
Publicado: (2022)

Pharmaceutical innovation and access to financial markets
por: Blau, Benjamin M., et al.
Publicado: (2022)

Pharmaceutical marketing: the example of drug samples
por: Alagha, Emily Couvillon, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rs7dpqvefpu2q2gltc3uqflrqt